These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 18380797)

  • 1. Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal.
    Lukivskaya O; Patsenker E; Lis R; Buko VU
    Eur J Clin Invest; 2008 May; 38(5):317-25. PubMed ID: 18380797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats.
    Islas-Carbajal MC; Covarrubias A; Grijalva G; Alvarez-Rodríguez A; Armendáriz-Borunda J; Rincón-Sánchez AR
    Liver Int; 2005 Feb; 25(1):131-40. PubMed ID: 15698410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of nitric oxide synthase isoforms.
    Chu CJ; Chang CC; Wang TF; Lee FY; Chang FY; Chen YC; Chan CC; Huang HC; Wang SS; Lee SD
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1194-9. PubMed ID: 16824075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
    Wei CL; Hon WM; Lee KH; Khoo HE
    Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.
    Mayoral P; Criado M; Hidalgo F; Flores O; Arévalo MA; Eleno N; Sánchez-Rodríguez A; López-Novoa JM; Esteller A
    Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
    Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia.
    Robinson EK; Seaworth CM; Suliburk JW; Adams SD; Kao LS; Mercer DW
    Shock; 2006 May; 25(5):507-14. PubMed ID: 16680016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
    Kaikita K; Schoenhard JA; Painter CA; Ripley RT; Brown NJ; Fogo AB; Vaughan DE
    J Mol Cell Cardiol; 2002 Jun; 34(6):617-27. PubMed ID: 12054849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase inhibitors modulate lipopolysaccharide-induced hepatocyte injury: dissociation between in vivo and in vitro effects.
    Farghali H; Canová N; Kucera T; Martínek J; Masek K
    Int Immunopharmacol; 2003 Nov; 3(12):1627-38. PubMed ID: 14555288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity.
    Ghaznavi R; Kadkhodaee M
    Arch Toxicol; 2007 Jun; 81(6):453-7. PubMed ID: 17039356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver tissue inducible nitric oxide synthase (iNOS) expression and lipid peroxidation in experimental hepatic ischemia reperfusion injury stimulated with lipopolysaccharide: the role of aminoguanidine.
    Yaylak F; Canbaz H; Caglikulekci M; Dirlik M; Tamer L; Ogetman Z; Polat Y; Kanik A; Aydin S
    J Surg Res; 2008 Aug; 148(2):214-23. PubMed ID: 18222473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of endothelial nitric oxide synthase maintains nitric oxide production in the cerebellum of thioacetamide cirrhotic rats.
    Hernández R; Martínez-Lara E; Del Moral ML; Blanco S; Cañuelo A; Siles E; Esteban FJ; Pedrosa JA; Peinado MA
    Neuroscience; 2004; 126(4):879-87. PubMed ID: 15207323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.
    Abramovitch S; Dahan-Bachar L; Sharvit E; Weisman Y; Ben Tov A; Brazowski E; Reif S
    Gut; 2011 Dec; 60(12):1728-37. PubMed ID: 21816960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.
    Kozlov AV; Sobhian B; Duvigneau JC; Costantino G; Gemeiner M; Nohl H; Redl H; Bahrami S
    J Lab Clin Med; 2002 Nov; 140(5):303-11. PubMed ID: 12434131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intervention with nitric oxide synthase inhibitors for traumatic shock in rats.
    Sun GB; Huang ZH; Sun YG; Yang WY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):306-9. PubMed ID: 12697459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic L-arginine administration increases oxidative and nitrosative stress in rat hyperoxaluric kidneys and excessive crystal deposition.
    Huang HS; Ma MC; Chen J
    Am J Physiol Renal Physiol; 2008 Aug; 295(2):F388-96. PubMed ID: 18448592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury.
    Yagnik GP; Takahashi Y; Tsoulfas G; Reid K; Murase N; Geller DA
    Hepatology; 2002 Sep; 36(3):573-81. PubMed ID: 12198649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats.
    Bruck R; Genina O; Aeed H; Alexiev R; Nagler A; Avni Y; Pines M
    Hepatology; 2001 Feb; 33(2):379-86. PubMed ID: 11172339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inhibition of NOS-2 ameliorates renal injury, as well as COX-2 and TGF-beta 1 overexpression in 5/6 nephrectomized rats.
    Bautista-García P; Sánchez-Lozada LG; Cristóbal-García M; Tapia E; Soto V; Avila-Casado MC; Márquez-Velasco R; Bojalil R; Franco M; Herrera-Acosta J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3074-81. PubMed ID: 16935907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.